Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11

Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders

Authors Ociskova M, Prasko J, Kamaradova D, Grambal A, Kasalova P, Sigmundova Z, Latalova K, Vrbova K

Received 5 January 2015

Accepted for publication 24 February 2015

Published 15 May 2015 Volume 2015:11 Pages 1191—1201

DOI https://doi.org/10.2147/NDT.S80325

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 5

Editor who approved publication: Dr Roger Pinder

Marie Ociskova,1,2 Jan Prasko,2 Dana Kamaradova,2 Ales Grambal,2 Petra Kasalova,2 Zuzana Sigmundova,2 Klara Latalova,2 Kristyna Vrbova2

1
Department of Psychology, Faculty of Arts, 2Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital Olomouc, Olomouc, Czech Republic

Background: Approximately 30%–60% of patients with neurotic spectrum disorders remain symptomatic despite treatment. Identifying the predictors of good response to psychiatric and psychotherapeutic treatment may be useful for increasing treatment efficacy in neurotic patients. The objective of this study was to investigate the influence of hope, coping strategies, and dissociation on the treatment response of this group of patients.
Methods: Pharmacoresistant patients, who underwent a 6-week psychotherapeutic program, were enrolled in the study. All patients completed the Clinical Global Impression (CGI) – both objective and subjective forms, Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI)-II at baseline and after 6 weeks. The COPE Inventory, the Adult Dispositional Hope Scale (ADHS), and the Dissociative Experiences Scale (DES) were completed at the start of the treatment.
Results: Seventy-six patients completed the study. The mean scores for all scales measuring the severity of the disorders (BAI, BDI-II, subjective and objective CGI) significantly decreased during the treatment. Several subscores of the COPE Inventory, the overall score of ADHS, and the overall score of DES significantly correlated with the treatment outcome. Multiple regression was used to find out which factors were the most significant predictors of the therapeutic outcomes. The most important predictors of the treatment response were the overall levels of hope and dissociation.
Conclusion: According to our results, a group of patients with a primary neurotic disorder, who prefer the use of maladaptive coping strategies, feel hopelessness, and have tendencies to dissociate, showed poor response to treatment.

Keywords: neurotic spectrum disorders, treatment efficacy, dissociation, coping strategy, hope

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Quality of life and coping strategies of outpatients with a depressive disorder in maintenance therapy – a cross-sectional study

Holubova M, Prasko J, Ociskova M, Grambal A, Slepecky M, Marackova M, Kamaradova D, Zatkova M

Neuropsychiatric Disease and Treatment 2018, 14:73-82

Published Date: 22 December 2017

Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study

Vrbova K, Prasko J, Ociskova M, Kamaradova D, Marackova M, Holubova M, Grambal A, Slepecky M, Latalova K

Neuropsychiatric Disease and Treatment 2017, 13:567-576

Published Date: 23 February 2017

Self-stigma and schizophrenia: a cross-sectional study

Vrbova K, Prasko J, Holubova M, Kamaradova D, Ociskova M, Marackova M, Latalova K, Grambal A, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:3011-3020

Published Date: 24 November 2016

Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders – a cross-sectional study

Holubova M, Prasko J, Matousek S, Latalova K, Marackova M, Vrbova K, Grambal A, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:3021-3030

Published Date: 24 November 2016

Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study

Holubova M, Prasko J, Ociskova M, Marackova M, Grambal A, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2677-2687

Published Date: 19 October 2016

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders

Prasko J, Grambal A, Kasalova P, Kamaradova D, Ociskova M, Holubova M, Vrbova K, Sigmundova Z, Latalova K, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:2659-2676

Published Date: 17 October 2016

Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder

Prasko J, Ociskova M, Grambal A, Sigmundova Z, Kasalova P, Marackova M, Holubova M, Vrbova K, Latalova K, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2539-2552

Published Date: 7 October 2016

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders

Grambal A, Prasko J, Kamaradova D, Latalova K, Holubova M, Marackova M, Ociskova M, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2439-2448

Published Date: 22 September 2016

Delirium as a complication of the surgical intensive care

Horacek R, Krnacova B, Prasko J, Latalova K

Neuropsychiatric Disease and Treatment 2016, 12:2425-2434

Published Date: 22 September 2016

Quality of life in borderline patients comorbid with anxiety spectrum disorders – a cross-sectional study

Grambal A, Prasko J, Kamaradova D, Latalova K, Holubova M, Sedláčková Z, Hruby R,

Patient Preference and Adherence 2016, 10:1421-1433

Published Date: 1 August 2016

Coping strategies and self-stigma in patients with schizophrenia-spectrum disorders

Holubova M, Prasko J, Hruby R, Latalova K, Kamaradova D, Marackova M, Slepecky M, Gubova T

Patient Preference and Adherence 2016, 10:1151-1158

Published Date: 24 June 2016

Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients

Ociskova M, Prasko J, Latalova K, Kamaradova D, Grambal A

Neuropsychiatric Disease and Treatment 2016, 12:1539-1551

Published Date: 24 June 2016

Unmet needs of bipolar disorder patients

Hajda M, Prasko J, Latalova K, Hruby R, Ociskova M, Holubova M, Kamaradova D, Mainerova B

Neuropsychiatric Disease and Treatment 2016, 12:1561-1570

Published Date: 24 June 2016

Quality of life and parental styles assessed by adolescents suffering from inflammatory bowel diseases and their parents

Jelenova D, Prasko J, Ociskova M, Latalova K, Karaskova E, Hruby R, Kamaradova D, Mihal V

Neuropsychiatric Disease and Treatment 2016, 12:665-672

Published Date: 23 March 2016

Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder

Vyskocilova J, Prasko J, Sipek J

Neuropsychiatric Disease and Treatment 2016, 12:625-639

Published Date: 14 March 2016

Coping strategies and quality of life in schizophrenia: cross-sectional study

Holubova M, Prasko J, Hruby R, Kamaradova D, Ociskova M, Latalova K, Grambal A

Neuropsychiatric Disease and Treatment 2015, 11:3041-3048

Published Date: 10 December 2015

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010